Thursday, 10 September 2015

Dry (Atrophic) Macular Degeneration Therapeutics Companies and Drugs Pipeline H2 2015 Review Market Research Report

Dry (Atrophic) Macular Degeneration Global Clinical Trials Review H2 2015

Summary

GlobalDatas clinical trial report Dry (Atrophic) Macular Degeneration Global Clinical Trials Review H2 2015" provides an overview of Dry (Atrophic) Macular Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Dry (Atrophic) Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region country (G7 & E7) phase trial status end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries conferences journals news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.


The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.


Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region Country (G7 & E7) Trial Status Trial Phase Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title Phase and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

List of Figures
Dry (Atrophic) Macular Degeneration Therapeutics Global Clinical Trials by Region (%) 2015* 7
Dry (Atrophic) Macular Degeneration Therapeutics Global Clinical Trials and Average Enrollment by Top Countries 2015* 8
Dry (Atrophic) Macular Degeneration Therapeutics Global Clinical Trials In Progress by Top Countries 2015* 9
Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Asia-Pacific Top Countries (%) 2015* 10
Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Europe Top Five Countries (%) 2015* 11
Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials North America Top Countries (%) 2015* 12


Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global regional and country level

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)